Cash Flow Perseus Proteomics, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-902.00
-1,102.00
-785.00
-597.00
-411.00
-839.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
98.00
66.00
90.00
-16.00
-10.00
226.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-719.00
-833.00
-564.00
-476.00
-422.00
-608.00
Cash Flow from Investing Activities
-75.00
-150.00
-212.00
-33.00
-2.00
-3.00
Cash Flow from Financing Activities
923.00
63.00
0.00
2,647.00
1,011.00
0.00
Net Cash Inflow / Outflow
126.00
-903.00
-769.00
2,145.00
586.00
-617.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-2.00
16.00
7.00
8.00
1.00
-5.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Perseus Proteomics, Inc.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
-902.34
-1288.709
386.00
29.98%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
98.59
-145.497
243.00
167.76%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-719.485
-1299.118
580.00
44.62%
Cash Flow from Investing Activities
-75.157
-10.005
-65.00
-651.19%
Cash Flow from Financing Activities
923.381
567.628
356.00
62.67%
Net Cash Inflow / Outflow
126.502
-741.229
867.00
117.07%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-2.237
0.266
-2.00
-940.98%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 13.72% vs -47.78% in Mar 2024
Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
-719.49
-833.90
13.72%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
